Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Sep;61(9):7046-7065.
doi: 10.1007/s12035-024-04020-y. Epub 2024 Feb 17.

The Synergistic Effect Study of Lipopolysaccharide (LPS) and A53T-α-Synuclein: Intranasal LPS Exposure on the A53T-α-Synuclein Transgenic Mouse Model of Parkinson's Disease

Qing He #  1 , Shuzhen Zhang #  2 , Jian Wang  3 , Tengfei Ma  4 , Ding Ma  4 , Li Wu  1 , Mengxi Zhou  1 , Lei Zhao  1 , Yajing Chen  1 , Jianren Liu  5 , Wei Chen  6
Affiliations

The Synergistic Effect Study of Lipopolysaccharide (LPS) and A53T-α-Synuclein: Intranasal LPS Exposure on the A53T-α-Synuclein Transgenic Mouse Model of Parkinson's Disease

Qing He et al. Mol Neurobiol. 2024 Sep.

Abstract

Aging and interactions between genetic and environmental factors are believed to be involved the chronic development of Parkinson's disease (PD). Among PD patients, abnormally aggregated α-synuclein is a major component of the Lewy body. Generally, the intranasal route is believed to be a gate way to the brain, and it assists environmental neurotoxins in entering the brain and is related to anosmia during early PD. The current study applies the chronic intranasal application of lipopolysaccharides (LPS) in 4-, 8-, 12- and 16-month-old A53T-α-synuclein (A53T-α-Syn) transgenic C57BL/6 mice at 2-day intervals for a 2-month period, for evaluating the behavioral, pathological, and biochemical changes and microglial activation in these animals. According to our results, after intranasal administration of LPS, A53T-α-Syn mice showed severe progressive anosmia, hypokinesia, selective dopaminergic (DAergic) neuronal losses, decreased striatal dopamine (DA) level, and enhanced α-synuclein accumulation within the substantia nigra (SN) in an age-dependent way. In addition, we found obvious NF-кB activation, Nurr1 inhibition, IL-1β, and TNF-α generation within the microglia of the SN. Conversely, the wild-type (WT) mice showed mild, whereas A53T-α-Syn mice had moderate PD-like changes among the old mice. This study demonstrated the synergistic effect of intranasal LPS and α-synuclein burden on PD development. Its underlying mechanism may be associated with Nurr1 inhibition within microglia and the amplification of CNS neuroinflammation. The mice with multiple factors, including aging, neuroinflammation, and α-synuclein mutation, have played a significant role in enhancing our understanding of how inflammation and α-synuclein mutation contribute to the neurodegeneration observed in PD.

Keywords: A53T-α-synuclein; Intranasal; LPS; Neuroinflammation; Parkinson’s disease.

PubMed Disclaimer

Similar articles

See all similar articles

References

    1. Rajan S, Kaas B (2022) Parkinson’s disease: risk factor modification and prevention. Semin Neurol 42(5):626–638. https://doi.org/10.1055/s-0042-1758780 - DOI - PubMed
    1. Forloni G (2023) Oligomers and neurodegeneration: new evidence. Aging Dis. https://doi.org/10.14336/ad.2023.0327 - DOI - PubMed - PMC
    1. Collier TJ, Kanaan NM, Kordower JH (2011) Ageing as a primary risk factor for Parkinson’s disease: evidence from studies of non-human primates. Nat Rev Neurosci 12(6):359–366. https://doi.org/10.1038/nrn3039 - DOI - PubMed - PMC
    1. Rodriguez M, Rodriguez-Sabate C, Morales I, Sanchez A, Sabate M (2015) Parkinson’s disease as a result of aging. Aging Cell 14(3):293–308. https://doi.org/10.1111/acel.12312 - DOI - PubMed - PMC
    1. Iba M, McDevitt RA, Kim C, Roy R, Sarantopoulou D, Tommer E, Siegars B, Sallin M et al (2022) Aging exacerbates the brain inflammatory micro-environment contributing to α-synuclein pathology and functional deficits in a mouse model of DLB/PD. Mol Neurodegener 17(1):60. https://doi.org/10.1186/s13024-022-00564-6 - DOI - PubMed - PMC

MeSH terms

LinkOut - more resources

-